Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is an open-labeled, cross-over design, pharmacokinetic study, to determine the pharmacokinetics of ALZT-OP1 (a combination drug therapy) designated as ALZT-OP1a and ALZT-OP1b, in both plasma and CSF, following co-administration of the active compounds, in healthy volunteers, aged 55-75, and in good general health.
Epistemonikos ID: 56b8324b37308577c8f9f3d5a939c16ab08fac88
First added on: May 12, 2024